Your browser doesn't support javascript.
loading
Adjuvant tyrosine kinase inhibitor therapy improves outcome for children and adolescents with acute lymphoblastic leukaemia who have an ABL-class fusion.
Moorman, Anthony V; Schwab, Claire; Winterman, Emily; Hancock, Jerry; Castleton, Anna; Cummins, Michelle; Gibson, Brenda; Goulden, Nick; Kearns, Pam; James, Beki; Kirkwood, Amy A; Lancaster, Donna; Madi, Mabrouk; McMillan, Andrew; Motwani, Jayashree; Norton, Alice; O'Marcaigh, Aengus; Patrick, Katharine; Bhatnagar, Neha; Qureshi, Amrana; Richardson, Deborah; Stokley, Simone; Taylor, Gordon; van Delft, Frederik W; Moppett, John; Harrison, Christine J; Samarasinghe, Sujith; Vora, Ajay.
Afiliação
  • Moorman AV; Wolfson Childhood Cancer Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Schwab C; Wolfson Childhood Cancer Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Winterman E; Wolfson Childhood Cancer Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Hancock J; Bristol Genetics Laboratory, North Bristol NHS Trust, Bristol, UK.
  • Castleton A; Department of Haematology, The Christie Hospital NHS Trust, Manchester, UK.
  • Cummins M; Department of Paediatric Oncology, Bristol Royal Hospital for Children, Bristol, UK.
  • Gibson B; Department of Haematology, Royal Hospital for Children, Glasgow, UK.
  • Goulden N; Department of Haematology, Great Ormond Street Hospital, London, UK.
  • Kearns P; Institute of Cancer and Genomic Sciences and NIHR Birmingham Biomedical Research Centre, University of Birmingham, Birmingham, UK.
  • James B; Regional Centre for Paediatric Haematology and Oncology, Leeds Children's Hospital, Leeds, UK.
  • Kirkwood AA; CR UK and UCL Cancer Trials Centre, UCL Cancer Institute, UCL, London, UK.
  • Lancaster D; Paediatric Oncology, The Royal Marsden Hospital, Sutton, UK.
  • Madi M; Department of Paediatric Oncology and Haematology, Leicester Royal Infirmary, Leicester, UK.
  • McMillan A; Centre for Clinical Haematology, Nottingham University Hospitals, Nottingham, UK.
  • Motwani J; Department of Haematology, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.
  • Norton A; Department of Haematology, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.
  • O'Marcaigh A; Department of Haematology, Children's Health Ireland, Dublin, Ireland.
  • Patrick K; Department of Haematology, Sheffield Children's NHS Foundation Trust, Sheffield, UK.
  • Bhatnagar N; Paediatric Haematology Department, Oxford Children's Hospital, Oxford, UK.
  • Qureshi A; Paediatric Haematology Department, Oxford Children's Hospital, Oxford, UK.
  • Richardson D; Department of Haematology, Southampton University Hospitals Trust, Southampton, UK.
  • Stokley S; Department of Paediatric Haematology, Nottingham Children's Hospital, Nottingham, UK.
  • Taylor G; Department of Haematology, Aberdeen Royal Infirmary, Aberdeen, UK.
  • van Delft FW; Wolfson Childhood Cancer Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Moppett J; Department of Paediatric Oncology, Bristol Royal Hospital for Children, Bristol, UK.
  • Harrison CJ; Wolfson Childhood Cancer Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Samarasinghe S; Department of Haematology, Great Ormond Street Hospital, London, UK.
  • Vora A; Department of Haematology, Great Ormond Street Hospital, London, UK.
Br J Haematol ; 191(5): 844-851, 2020 12.
Article em En | MEDLINE | ID: mdl-32926422

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Inibidores de Proteínas Quinases / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudo: Prognostic_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Inibidores de Proteínas Quinases / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudo: Prognostic_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article